Clopidogrel
Clopidogrel is a pharmaceutical drug with 400 clinical trials. Currently 26 active trials ongoing. Historical success rate of 91.8%.
Success Metrics
Based on 268 completed trials
Phase Distribution
Phase Distribution
59
Early Stage
54
Mid Stage
243
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.0%
268 of 301 finished
11.0%
33 ended early
26
trials recruiting
400
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Clopidogrel Versus Cilostazol on Vessels
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Clinical Trials (400)
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Clopidogrel Versus Cilostazol on Vessels
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.
The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol
Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 400